Skip to main content
. 2021 Sep 2;16:2503–2513. doi: 10.2147/COPD.S321877

Figure 5.

Figure 5

RELMβ promotes the expression of the inflammatory factors IL-8 and IL-1β via the p38 MAPK signaling pathway. (A-B) Western blotting and bar graphs showing the expression of p-p38 MAPK, IL-8, and IL-1β in the 16HBE cells in the parental control, null and RELMβ overexpression groups after treatment with the p38 MAPK inhibitor sb203580. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.